Michael Scolaro

Michael Scolaro

Nov 29, 2017

Group 6 Copy 175
1
References
  • 1. https://www.ncbi.nlm.nih.gov/pubmed/26558876
  • 2. https://www.ncbi.nlm.nih.gov/pubmed/26558876
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Decreasing the Risk of Death and Diving Injuries in Artisanal Fishermen

Artisanal fishermen risk their lives every day to support their families and communities. Using outdated technology...

Can Data Management Tools Improve Research Efficiency and Reproducibility?

Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

Are Emergency Doctors Uncomfortable Treating Patients in Psychiatric Crisis? If so, Why?

This survey research study aims to explore the amount of confidence emergency physicians have with treating...

Backer Badge Funded